Study to Evaluate the Bioequivalence of Vonopzan Tablet 20mg(Vonoprazan Fumarate) and Vocinti Tablet 20mg in Healthy Adult Subjects.
Clinical trial NCT06642987 · COMPLETED
Trial details
- NCT number
- NCT06642987
- Sponsor
- Hanlim Pharm. Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-23
- Primary completion
- 2023-11-03
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.